Amantea D, Corasaniti M T, Mercuri N B, Bernardi G, Bagetta G
Department of Pharmacobiology, University of Calabria, via P. Bucci, Ed. Polifunzionale, 87036 Rende (CS), Italy.
Neuroscience. 2008 Mar 3;152(1):8-17. doi: 10.1016/j.neuroscience.2007.12.030.
Matrix metalloproteinases (MMPs) have been implicated in the pathophysiology of ischemic stroke. In particular, the gelatinases MMP-2 and MMP-9 contribute to disruption of the blood-brain barrier and hemorrhagic transformation following ischemic injury. In addition to extracellular matrix degradation, MMPs may directly regulate neuronal cell death through mechanisms that are not completely understood. Here we describe the spatio-temporal distribution of activated MMP-2 and MMP-9 in the brain of rats subjected to 2 h middle cerebral artery occlusion (MCAo) followed by different periods of reperfusion (15 min, 2 h, 6 h and 22 h). By in situ zymography we have observed that gelatinases become activated 15 min and 2 h after the beginning of reperfusion in the ischemic core and penumbra, respectively. In situ zymography signal broadly co-localized with NeuN-positive cells, thus suggesting that proteolysis mainly occurs in neurons. Gelatinolytic activity was mainly detected in cell nuclei, marginally appearing in the cytosol only at later stages following the insult; we did not detect variations in gelatinolysis in the extracellular matrix. Finally, we report that pharmacological inhibition of MMPs by N-[(2R)-2-(hydroxamidocarbonyl-methyl)-4-methylpenthanoyl]-L-tryptophan methylamide (GM6001) significantly reduces brain infarct volume induced by transient MCAo. Taken together our data underscore the crucial role of gelatinases during the early stages of reperfusion and further extend previous observations documenting the detrimental role of these enzymes in the pathophysiology of brain ischemia.
基质金属蛋白酶(MMPs)与缺血性中风的病理生理学有关。特别是,明胶酶MMP-2和MMP-9会导致血脑屏障破坏以及缺血性损伤后的出血性转化。除细胞外基质降解外,MMPs可能通过尚未完全了解的机制直接调节神经元细胞死亡。在此,我们描述了在经历2小时大脑中动脉闭塞(MCAo)并随后进行不同时长再灌注(15分钟、2小时、6小时和22小时)的大鼠大脑中,活化的MMP-2和MMP-9的时空分布。通过原位酶谱分析,我们观察到在再灌注开始后15分钟和2小时,明胶酶分别在缺血核心区和半暗带被激活。原位酶谱分析信号与NeuN阳性细胞广泛共定位,因此表明蛋白水解主要发生在神经元中。明胶酶解活性主要在细胞核中检测到,仅在损伤后的后期才在细胞质中少量出现;我们未检测到细胞外基质中明胶酶解的变化。最后,我们报告称,N-[(2R)-2-(羟氨基羰基甲基)-4-甲基戊酰基]-L-色氨酸甲酰胺(GM6001)对MMPs的药理抑制作用显著减小了短暂性MCAo诱导的脑梗死体积。综上所述,我们的数据强调了明胶酶在再灌注早期阶段的关键作用,并进一步扩展了先前关于这些酶在脑缺血病理生理学中有害作用的观察结果。